Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus.

Autor: Edwards KR; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA., Schmidt K; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Homad LJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Kher GM; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Xu G; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA., Rodrigues KA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, USA., Ben-Akiva E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, USA; Departments of Biological Engineering and Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Abbott J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Prlic M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Immunology, University of Washington, Seattle, WA, USA., Newell EW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA., Irvine DJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, USA; Harvard-MIT Health Sciences and Technology Program, Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA., Pancera M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., McGuire AT; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USA; Department of Global Health, University of Washington, Seattle, WA, USA; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA. Electronic address: amcguire@fredhutch.org.

Publikováno v: Cell reports. Medicine [Cell Rep Med] 2024 Jun 18; Vol. 5 (6), pp. 101587. Date of Electronic Publication: 2024 May 22.

Characteristics of self-regulation of the epidemic process of infection caused by the Epstein-Barr virus (Herpesviridae: Lymphocryptovirus , HHV-4).

Autor: Solomay TV; Central Research Institute of Epidemiology of Rospotrebnadzor.; I.I. Mechnikov Scientific Research Institute of Vaccines and Serums, Ministry of Education and Science of Russia., Semenenko TA; National Research Center of Epidemiology and Microbiology named after Honorary Academician N.F. Gamalei of the Ministry of Health of Russia.; I.M. Sechenov First Moscow State Medical University of the Ministry of Health of Russia (Sechenov University)., Akimkin VG; Central Research Institute of Epidemiology of Rospotrebnadzor.

Publikováno v: Voprosy virusologii [Vopr Virusol] 2023 Sep 21; Vol. 68 (4), pp. 343-354. Date of Electronic Publication: 2023 Sep 21.

Epstein–Barr virus (Orthoherpesviridae: Lymphocryptovirus) among Russian ethnic groups: Prevalence of EBV types (EBV-1 and EBV-2), LMP1 gene variants and malignancies

Autor: Vladimir E. Gurtsevitch, Alexandra K. Lubenskaya, Natalia B. Senyuta, Ksenia V. Smirnova

Publikováno v: Вопросы вирусологии, Vol 69, Iss 1, Pp 56-64 (2024)

Introduction. The discovery of two EBV types (EBV-1 and EBV-2) has stimulated the study of their prevalence in populations and association with malignancies. Objective. To study the prevalence of EBV-1 and EBV-2 types among ethnic groups in Russia

Externí odkaz: https://doaj.org/article/a43e8d48cabd4321892e78dd18b44189

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Characteristics of self-regulation of the epidemic process of infection caused by the Epstein–Barr virus (Herpesviridae: Lymphocryptovirus, HHV-4)

Autor: Tatyana V. Solomay, Tatiana A. Semenenko, Vasiliy G. Akimkin

Publikováno v: Вопросы вирусологии, Vol 68, Iss 4, Pp 343-354 (2023)

Introduction. Among the available scientific literature, there are no publications addressing processes of self-regulation in the parasite-host population systems with reference to chronic infections, including the infection caused by the EpsteinBarr

Externí odkaz: https://doaj.org/article/8df844684b4940c888c52aa40f43f437